New award for entecavir tablets with avkare, LLC. Period of performance is december 28TH, 2020 to december 27TH, 2021 with four one-year options.

Ended Indefinite Delivery Contract Awarded Dec 28, 2020 Last action Dec 14, 2022

Contract number: 36E79721D0005
Awardee: Avkare LLC UEI SFPGXE6XPS93
Awarding agency: National Acquisition Center Headquarters, Department of Veterans Affairs
Task orders: 0

Award facts

Opportunity: 6505--Entecavir Tablets Pre-Solicitation · 36E79720R0065 · Posted Aug 6, 2020

6505--Entecavir Tablets Effective 12/28/2020-12/27/2021 Award Notice · Posted Oct 28, 2020

6505--Entecavir Tablets Solicitation · Posted Aug 31, 2020
Last date to order 100% complete: Dec 27, 2022
IDV ceiling: $14,965,328.90
Award type: Single award
Contracting staff: Stevan Vasich
NAICS code: 325412 Pharmaceutical Preparation Manufacturing
PSC: 6505 Drugs And Biologicals
Set-aside: No set-aside
Competition: Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing: Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI · Jan 5, 2024

The Department of Veterans Affairs National Acquisition Center awarded Avkare, LLC a single-award indefinite delivery contract with a potential value of $14,965,328.90 to supply entecavir tablets. The contract utilizes no set-asides and has a base period of performance from December 28, 2020 to December 27, 2021, including four one-year option periods extending to December 27, 2025.

The originating pre-solicitation notice sought offers for an unrestricted procurement of entecavir tablets to supply the VA, DoD, BOP and IHS through their respective Pharmaceutical Prime Vendor programs. The solicitation planned distribution of approximately 32,117 bottles annually of 0.5mg and 1mg entecavir tablets to treat hepatitis B. Avkare will provide the contracted tablets under the label name and unique NDC number stated in their offer. The contract aims to ensure an uninterrupted supply of this medication across multiple federal healthcare agencies through its indefinite delivery structure.

Transactions

Action	Obligated	Date
Other Administrative Action P00006 · Government's notice that IT will not exercise 2ND option year for entecavir tablets contract 36E79721D0005 with avkare, LLC. Contract will expire on…	$0	Dec 14, 2022
Add Subcontract Plan P00005 · Incorporate 2023 small business subcontracting plan into contract.	$0	Nov 10, 2022
Add Subcontract Plan P00004 · This modification is issued to incorporate avkare LLC's 2022 subcontracting plan effective for the period of january 1, 2022-december 31, 2022.	$0	Dec 20, 2021
Exercise an Option P00003 · Exercise option year 1 for entecavir. Period of performance is 12/28/2021 - 12/27/2022.	$0	Nov 4, 2021
Other Administrative Action P00002 · Contractor POC changes.	$0	Jul 19, 2021
Add Subcontract Plan P00001 · This modification is issued to incorporate avkare, LLC's 2021 subcontracting plan effective for the period of january 1, 2021-december 31, 2021.	$0	Dec 17, 2020
Original award	$0	Oct 28, 2020

Quick answers

Who was awarded contract 36E79721D0005?

36E79721D0005 was awarded to Avkare LLC by National Acquisition Center (Headquarters) on December 28, 2020.

How much is contract 36E79721D0005 worth?

36E79721D0005's own ceiling is $14,965,329.

Who can order from contract 36E79721D0005?

36E79721D0005 is a single award indefinite delivery contract.

Was contract 36E79721D0005 competed?

The extent of competition for 36E79721D0005 was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

Every order and transaction
The awardee's other awards and teaming partners
Similar IDVs and recompete opportunities
Ask GovTribe AI about this IDV

Try for free Login